Open mobile menu
Jroberts Jruaux Dpingstone 03 B012378 CROPPED
Insights

News

Stay up to date with news about Secerna and intellectual property topics.

VENCLEXTA®

A to Z: Drugs in Highlight: V is for VENCLEXTA®

News A to Z Feature 30/04/2025

Our A to Z series highlights VENCLEXTA® (venetoclax) from AbbVie, a medication used to treat both chronic lymphocytic leukaemia (CLL) and acute myeloid leukaemia (AML). This article explores its mechanism of action, clinical applications, and the patent protection surrounding this important drug.

Read more
EU Standing Flags Unsplash
European 20/02/2021

European Patent Office 2021 guidelines

Article 3 JXR Lightbulb
News 20/01/2021

Quantum Technologies – A Patent Perspective

Article 2 JXR Lock
News 15/01/2021

Quantum Key Distribution – Data Security of the Future?

Article 1 JXR Quantum Computer Technology
Industry news, News 10/01/2021

The rise of quantum technology

New Office 2019
News 05/01/2021

Secerna appointment supports drive for environmental technology

Clare Burnard 1
Team news 09/12/2020

Get to know Clare Burnard, Secerna Executive Assistant/Office Manager

B013040
Team news, Careers 10/11/2020

Thomas Kennelly - A day in the life of a Part Qualified Patent Attorney

EUR And UK
European 15/10/2020

Brexit - Down to the wire

Newcastle Tyne Bridge [Unsplash]
News 15/09/2020

6 Reasons to live and work in Newcastle

25 26 27 28 29 30 31 32 33 34 35